Publications by authors named "Timothy G Mant"

Claim this Profile
A
A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation.
Joseph A Jakubowski, Chunmei Zhou, Stipo Jurcevic, Kenneth J Winters, D Richard Lachno, Timothy G Mant

Thromb Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity.
Joseph A Jakubowski, Chunmei Zhou, David S Small, Kenneth J Winters, D Richard Lachno, Timothy G Mant

Br J Clin Pharmacol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers.
Svetlana Borozdenkova, Timothy G K Mant, Elizabeth Allen, Kewei Pu, Shoji Hoshino

Int Immunopharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers.
Timothy G K Mant, Svetlana Borozdenkova, Daniel B A Bradford, Elizabeth Allen, Dipti M Amin

Int Immunopharmacol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of food on the pharmacokinetics of a formulated ACP-103 tablet in healthy volunteers.
Kimberly E Vanover, Doris Robbins-Weilert, Darren G Wilbraham, Timothy G K Mant, Daniel P van Kammen

J Clin Pharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers.
Kimberly E Vanover, Doris Robbins-Weilert, Darren G Wilbraham, Timothy G K Mant, Daniel P van Kammen

J Clin Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.
Timothy G K Mant, Daniel Bradford, Dipti M Amin, Jaya Pisupati, Yoshikazu Kambayashi

Br J Clin Pharmacol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha.
K Lea Sewell, Richard S Geary, Brenda F Baker, Josephine M Glover, Timothy G K Mant

J Pharmacol Exp Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis